These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2434699)

  • 1. [Function of terminal complement complex and control protein in renal disease (renal localization and serum levels of S protein, and detection of the SC5b-9 complex)].
    Kojima H; Ohi H; Seki M; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Nov; 28(11):1449-56. PubMed ID: 2434699
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
    Mrowka C; Sieberth HG
    Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.
    Preissner KP; Podack ER; Müller-Eberhard HJ
    Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.
    Murphy BF; Kirszbaum L; Walker ID; d'Apice AJ
    J Clin Invest; 1988 Jun; 81(6):1858-64. PubMed ID: 2454950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].
    Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):302-5. PubMed ID: 8168211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.
    Falk RJ; Dalmasso AP; Kim Y; Lam S; Michael A
    N Engl J Med; 1985 Jun; 312(25):1594-9. PubMed ID: 4000197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.
    Halstensen TS; Mollnes TE; Brandtzaeg P
    Immunology; 1988 Oct; 65(2):193-7. PubMed ID: 2461343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of plasma SC5b-9 (SMAC) in patients with ARDS].
    Hara N; Abe M; Kawarada Y; Inuzuka S; Takahashi H; Goya T; Shigematsu N; Fujita T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):796-801. PubMed ID: 1630043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis].
    Kojima H; Ohi H; Seki M; Hatano M
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):925-31. PubMed ID: 2585834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephritis and complement].
    Sugiyama S
    Rinsho Byori; 1992 Oct; 40(10):1021-6. PubMed ID: 1307603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor.
    Biesecker G
    J Immunol; 1990 Jul; 145(1):209-14. PubMed ID: 1694202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
    Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the membrane attack complex (MAC) in acute poststreptococcal glomerulonephritis].
    Oshima S; Yoshizawa N
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):811-9. PubMed ID: 3249448
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.
    Lai KN; Lo ST; Lai FM
    Am J Pathol; 1989 Sep; 135(3):469-76. PubMed ID: 2675624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.